Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GeNO obtains new patent for Nitrosyl nitric oxide product
The newly-issued patent relates to the GeNO cartridge technology that eliminates nitrogen dioxide (NO2) from the gas being delivered to the patient. Out of two Phase 2 trials,
The newly-issued patent relates to the GeNO cartridge technology that eliminates nitrogen dioxide (NO2) from the gas being delivered to the patient. Out of two Phase 2 trials,
Pursuant to the proposed merger, Evolva is expected to take over 100% of the share capital of Abunda in return for 25m Evolva shares (12.9% of Evolva’s share
Abstral , which is already marketed by ProStrakan across the European markets has got the US Food and Drug Administration approval in January 2011. Abstral is based on
As per the terms of the agreement, Neomycin Sulfate tablets will be manufactured by Oman Pharma, and marketed and distributed by Breckenridge on an exclusive basis in the
Tafamidis is an oral experimental compound which is used to treat the patients who are suffering from Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP). FDA said the NDA which was
Prior to Daiichi Sankyo, Gargiulo worked as the senior vice president of Commercial Operations where he was responsible for the company’s US marketing, Supply Chain, Managed Markets and
TX-RAD is a type 1 regulatory T cell based immunotherapy used for the treatment of joint inflammatory diseases like rheumatoid arthritis. The study RATS1 (Rheumatoid arthritis And Tr1
The single-use cell cassettes are the central component used in Aastrom’s proprietary culturing process at its cell manufacturing facility in Ann Arbor, Michigan. In addition, Aastrom’s ixmyelocel-T has
The tie up aims to identify new chemical compounds that slow down the activity of novel protein target, proposed by IPD. The results of the computational analysis will
Prior to the NOA, BioLineRx has received approval for BL-1020 drug in Australia, Korea and China. In pre-clinical and clinical trials, BL-1020 was effective at treating schizophrenia symptoms